戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 RRP = resorufin phosphate, DUT = Dyomics-647 uridine triphosphate).
2              Application of the P2Y agonists uridine triphosphate (15 microM) and adenosine 5'-0-(Z-t
3 bstantial levels of 2'-deoxy-2'-spirooxetane uridine triphosphate (8), a potent inhibitor of the HCV
4           Inserted U's are derived from free uridine triphosphate and are added to the 3' terminus of
5 ed overflow metabolism allows homeostasis of uridine triphosphate and cytidine triphosphate levels at
6 (UGP) alternatively makes UDP-galactose from uridine triphosphate and galactose-1-phosphate.
7 , epidermal growth factor increased cellular uridine triphosphate and this increase was reversed by i
8 s feedback inhibition (which is dependent on uridine triphosphate) and became more sensitive to activ
9  uridine monophosphate, uridine diphosphate, uridine triphosphate, and their nonphosphate compound-ur
10 ubstrate, whereas nsp12-V792I diminished the uridine triphosphate concentration needed to overcome te
11                               An analogue of uridine triphosphate containing a cationic functional gr
12 onists, such as lysophosphatidic acid (LPA), uridine triphosphate, growth hormone, vascular endotheli
13 ate (ATP) > or = 5'adenosine-diphosphate > 5'uridine-triphosphate > or = 5'uridine-diphosphate, suppo
14                                We found that uridine triphosphate-mediated (UTP-mediated) Cl(-) secre
15                                We found that uridine triphosphate-mediated (UTP-mediated) Cl- secreti
16 situ terminal deoxynucleotidyl transferase d-uridine triphosphate nick end labeling (TUNEL) assay, DN
17                     Increased terminal deoxy uridine triphosphate nick end labeling positivity was ob
18        Using both terminal deoxy transferase uridine triphosphate nick end-labelling and poly ADP-rib
19                                   Two analog uridine triphosphates tethering additional functionality
20                             5-(3-Aminopropyl)uridine triphosphate (UNH(2)) as a uridine substitute wa
21 or T7 RNA polymerase than 5-(2-mercaptoethyl)uridine triphosphate (USH).
22 last growth factor (bFGF), by the pyrimidine uridine triphosphate (UTP) and by hypotonicity.
23  was mediated by elevations in intracellular uridine triphosphate (UTP) and cytidine triphosphate (CT
24 ate (ADP), adenosine triphosphate (ATP), and uridine triphosphate (UTP) dose dependently increased th
25       In view of recent data indicating that uridine triphosphate (UTP) is the physiologic phosphate
26                                       Apical uridine triphosphate (UTP) stimulation was shown to incr
27              However, vasoconstrictors (e.g. uridine triphosphate (UTP)) and growth factors, which el
28 to approximately 79% of the peak response to uridine triphosphate (UTP), a P2Y agonist (n = 19).
29                            Two sets of (35)S-uridine triphosphate (UTP)-labeled antisense and sense r
30 hanced the [Ca(2+)](i) increase generated by uridine triphosphate (UTP).
31 s that were similar in magnitude to those of uridine triphosphate (UTP).
32 phate (2MeSADP) or the P2Y2/P2Y4 R agonist 5'uridine-triphosphate (UTP) were reduced but not abolishe
33                                              Uridine triphosphate was the preferred nucleotide in thi
34                     Six 1',5'-anhydrohexitol uridine triphosphates were synthesized with aromatic sub